| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |